Literature DB >> 15377804

Remission of HIV-associated myelopathy after highly active antiretroviral therapy.

F J Fernández-Fernández1, J de la Fuente-Aguado, A Ocampo-Hermida, A Iglesias-Castañón.   

Abstract

HIV-associated myelopathy is the leading cause of spinal cord disease in HIV-infected patients. Typically, it affects individuals with low CD4 T cell counts, presenting with slowly progressive spastic paraparesis associated with dorsal column sensory loss as well as urinary disturbances. Other aetiologies must be first ruled out before establishing the diagnosis. We report here the case of a 37-year-old woman with advanced HIV disease, who developed HIV-associated myelopathy. The patient showed a gradual improvement after beginning with highly active antiretroviral therapy and, finally, she achieved a complete functional recovery. In addition, neuroimaging and neurophysiological tests normalized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377804

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  2 in total

1.  Spastic paraparesis caused by X-linked adrenoleukodystrophy mimicking vacuolar myelopathy in a human immunodeficiency virus patient: A case report.

Authors:  Jin-Sung Park; Donghwi Park
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

2.  Successful Treatment of Human Immunodeficiency Virus-Associated Highly Active Antiretroviral Therapy-Resistant Vacuolar Myelopathy with Intravenous Immunoglobulin.

Authors:  Lidiia N Prakhova; Aleksandr G Ilves; Svetlana N Kizhlo; Zhanna I Savintseva
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.